Articles

Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter the market. Often presenting a more cost-effective alternative, biosimilars...

For companies in the early stages of developing a new parenteral therapy, the focus within the product teams is naturally on the molecule and the science behind it. But when it’s time to transition...

Viral vectors play a vital role in the development of cell and gene therapies (C&GTs). By delivering genetic material to patients’ cells to replace dysfunctional or damaged DNA, these complex tools have helped to...

The healthcare industry has undergone evident transformations in the past ten years. Innovations involving artificial intelligence (AI) driven technologies have uplifted diagnostics and aftercare, and have improved patient experience significantly. Furthermore, investments in health...

With sustainability as a daily challenge and energy in short supply, a dependable management plan is essential If someone asks me today, “As an executive in the biopharma industry, what are the issues that keep...

Reacting rapidly after the initial onset of the pandemic the biopharma industry accelerated its research into advanced anti-viral modalities including messenger RNA (mRNA) vaccines. As the pharma industry’s leaders responded to the crisis, the...

Introduction The clinical research industry wants to achieve the common goal of accelerating drug development by improving the process of data collection, data validation, analysis, and submission. Faster time to market puts pressure on every...

Just 10 months ago, pharma and biotech companies rode a wave of pandemic-driven innovation and historic funding levels into what many hoped would be another banner year. Now, after several quarters of shifting expectations,...

For companies developing new injectable medications, manufacturing issues have become one of the greatest and most consistent early stumbling blocks. In fact, the FDA has issued more than 600 manufacturing citations in just the...

High-throughput screening (HTS) is a method for drug discovery that allows automated testing of large numbers of chemical and biological compounds for a specific biological target. Mass spectrometry is particularly appealing for HTS as...